Using our approach, we've already been able to program cells to make new molecules, including molecules from an important class of drugs known as depsipeptide macrocycles.

使用我们的方法，我们已经能够对细胞进行编程以制造新分子，包括来自一类重要药物的分子，称为缩酚肽大环化合物。